Rallis India: Good Q1 but Street looks for more recovery signs

Higher raw material prices, rising generics share in portfolio, lower Bt cotton seed prices could weigh on profit

Rallis India: Good Q1 but Street looks for more recovery signs
Ujjval Jauhari
Last Updated : Jul 20 2018 | 8:27 AM IST
Rallis India’s performance in the June quarter (Q1), after a weak show in the January-March period, should provide some respite to investors. However, it might be too early to celebrate.

Revenue grew 54.4 per cent sequentially and 29.7 per cent over a year in Q1, driven by strong performance in standalone operations (up 45 per cent over a year). Part of this surge is due to the low domestic base of last year, which was impacted by channel destocking ahead of implementation of the goods and services tax. However, recent price increases, better placement of generics, higher export, led by an improving situation in key markets such as Brazil, and strong demand for herbicides did help improve business performance.

Operating profit margins at 14.5 per cent also improved, over 9.1 per cent in the previous quarter but are still a 100 basis points less over a year. Higher prices of Chinese chemicals (inputs) and lower Bt cotton seed prices (impacted Metahalix’s margins) continue to weigh on profit. The Metahelix seed business’ growth of 13.4 per cent, however, remains healthy.

While Q1 performance will address some Street concerns, including on market share, the September quarter performance will be closely watched to confirm recovery. Notably, the September quarter is seasonally strong for Rallis and the management also instigated confidence citing satisfactory progress of the southwest monsoon and sowing activities, while expectations on total acreages are also catching up with that of last year.

What could spoil the recovery is continuing pressure on raw material due to higher chemical prices ex-China, which remains a key monitorable. Rallis has taken price increases in Q1 to partially mitigate the impact of higher costs but analysts say the industry is hesitant to take significant price increase in agrochemicals. The higher share of generics in portfolio, which earns lower margins, adds to Street concerns.

“Margin pressure is expected to continue in the September quarter, while demand pick-up hinges on kharif sowing, pest infestation and prevailing crop prices,” say analysts at Prabhudas Lilladher. Analysts at Edelweiss say they prefer to monitor the ensuing quarter’s performance to change their view on Rallis.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story